Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis-Reference-Cited by-同舟云学术

Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis

Published:2020-11-24 Issue:11 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Parry Smith William R¹,Papadopoulou Argyro¹,Thomas Eleanor¹,Tobias Aurelio¹,Price Malcolm J¹,Meher Shireen²,Alfirevic Zarko³,Weeks Andrew D³,Hofmeyr G Justus⁴,Gülmezoglu Ahmet Metin⁵,Widmer Mariana⁶,Oladapo Olufemi T⁶,Vogel Joshua P⁷,Althabe Fernando⁶,Coomarasamy Arri¹,Gallos Ioannis D¹

Affiliation:

1. WHO Collaborating Centre for Global Women’s Health Research, Institute of Metabolism and Systems Research, School of Medical and Dental Sciences; University of Birmingham; Birmingham UK

2. Birmingham Women's Hospital; Birmingham UK

3. Department of Women's and Children's Health; The University of Liverpool; Liverpool UK

4. Department of Obstetrics and Gynaecology; University of Botswana; University of Fort Hare, University of the Witwatersrand, Eastern Cape Department of Health; East London South Africa

5. Concept Foundation; Geneva Switzerland

6. UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research; World Health Organization; Geneva Switzerland

7. Maternal and Child Health; Burnet Institute; Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference66 articles.

1. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial;Blum;Lancet,2010

2. Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: results from a randomized non-inferiority trial among women receiving prophylactic oxytocin;Blum;International Journal of Gynecology & Obstetrics,2009

3. Side effect profiles for misoprostol and oxytocin in the treatment of postpartum hemorrhage;Dao;International Journal of Gynecology & Obstetrics,2009

4. Misoprostol for the treatment of postpartum hemorrhage clinicaltrials.gov/ct2/show/NCT00116350

5. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357];Hofmeyr;BMC Pregnancy and Childbirth,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MODERN VIEWS ABOUT PREDICTIONS OF POSTPARTUM BLEEDINGS;V.F.Snegirev Archives of Obstetrics and Gynecology;2024-09-09

2. Evidence‐based interventions to address persistent maternal mortality rates;Ultrasound in Obstetrics & Gynecology;2024-07-15

3. Higher Plasma Myo-Inositol in Pregnancy Associated with Reduced Postpartum Blood Loss: Secondary Analyses of the NiPPeR Trial;Nutrients;2024-06-27

4. Strategies for optimising early detection and obstetric first response management of postpartum haemorrhage at caesarean birth: a modified Delphi-based international expert consensus;BMJ Open;2024-05

5. Burden and outcomes of postpartum haemorrhage in Nigerian referral‐level hospitals;BJOG: An International Journal of Obstetrics & Gynaecology;2024-04-30